Drugs / Nicotine lozenge
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03722966 | Jan 2020 → Feb 2022 | — | University of Oklahoma | Terminated | No outcome recorded Stop: Enrollment |
| Phase 42 trials · 1 missed | ||||||
| Phase 4 | NCT02271919 | May 2015 → Jun 2025 | nicotine dependence | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 4 | NCT01553084 | May 2012 → Nov 2015 | nicotine dependence | University of Wisconsin, Madison | Completed | Missed primary |
| Phase not applicable1 trial | ||||||
| — | NCT01522963 | Dec 2011 → Jan 2014 | nicotine dependence | University of Minnesota | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 4 | NCT00586482 Comparator | Aug 2006 → Jan 2013 | — | Mayo Clinic | Completed | No outcome recorded |
| — | NCT05014282 Background | Dec 2021 → Sep 2025 overdue | — | H. Lee Moffitt Cancer Center and Research Institute | Active not recruiting | No outcome recorded |
| — | NCT02873754 Background | Jan → Jul 2017 | — | Duke University | Completed | No outcome recorded |
| — | NCT02869451 Background | Aug 2016 → May 2017 | cannabis dependence | Duke University | Completed | No outcome recorded |
| — | NCT02157610 Background | Jan 2015 → Aug 2021 | cervical cancer, nicotine dependence | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nicotine lozenge | “Nicotine Lozenge (4mg)” NCT03722966 ↗ |
| Modality | Other / unclassified | “oral nicotine replacement therapy (4mg gum or 4mg lozenge, depending on preference; to be used every 1-2 hours as urges occur)” NCT03722966 ↗ |
| Route | Oral | “taken without restriction by mouth” NCT00586482 ↗ |